PubRank

R M Esnouf

Author PubWeight™ 15.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. J Med Chem 1996 2.29
2 Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001 1.66
3 SPINE high-throughput crystallization, crystal imaging and recognition techniques: current state, performance analysis, new technologies and future aspects. Acta Crystallogr D Biol Crystallogr 2006 1.31
4 SPINE workshop on automated X-ray analysis: a progress report. Acta Crystallogr D Biol Crystallogr 2006 1.17
5 Crystal structures of HIV-1 reverse transcriptase in complex with carboxanilide derivatives. Biochemistry 1998 1.16
6 3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes. Proc Natl Acad Sci U S A 1998 1.14
7 SPINE bioinformatics and data-management aspects of high-throughput structural biology. Acta Crystallogr D Biol Crystallogr 2006 1.08
8 Crystals of HIV-1 reverse transcriptase diffracting to 2.2 A resolution. J Mol Biol 1994 1.06
9 Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses. J Biol Chem 2000 0.99
10 Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase. J Biol Chem 1998 0.93
11 Crystallographic analysis of the binding modes of thiazoloisoindolinone non-nucleoside inhibitors to HIV-1 reverse transcriptase and comparison with modeling studies. J Med Chem 1999 0.81
12 Nearest-cell: a fast and easy tool for locating crystal matches in the PDB. Acta Crystallogr D Biol Crystallogr 2012 0.78
13 A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152. J Gen Virol 1998 0.77
14 Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients. AIDS Res Hum Retroviruses 2000 0.75